Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
Yeah I guess a way to think of it is -- these biotech companies are just cash burning machines and deserve a very low valuation until they get good data on a compelling indication. So there are a lot more 10-20 baggers out there waiting for their drug(s) to prove themselves in trials.

But also -- all these AD plays are going after the same patients. Even if you have a good drug, it may not be the BEST drug and ultimately may not get approved or get good market share. So to be LTBH you have to really understand the competitive space. Right now I think all Alzheimers drugs are in favor, people just throwing money at the category now that FDA approved one drug, they think BIIB's results are relatively easy one to improve upon.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.